Metraipolis › archive › dc_fffbcf91552e

Lutetium-177 radiopharmaceuticals in cancer care: progress and challenges — Europe PMC PMID:42769817

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42769817
DOI
10.3389/fphar.2026.1907065
License (as archived)
solo-consultazione
Archived
2026-10-15T23:34:19.185Z
SHA-256 of the archived text
3031481386e4e3d06ac10871826941449122527dbed967d80998073b3fe487a6
Stable URL of this page
https://metraipolis.com/documento/dc_fffbcf91552e

How to cite

Lutetium-177 radiopharmaceuticals in cancer care: progress and challenges — Europe PMC PMID:42769817 — Europe PMC (en), https://europepmc.org/article/MED/42769817 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fffbcf91552e (Metraipolis archive dc_fffbcf91552e, sha256 3031481386e4e3d06ac10871826941449122527dbed967d80998073b3fe487a6)
BibTeX
@misc{dcfffbcf91552e,
  title = {Lutetium-177 radiopharmaceuticals in cancer care: progress and challenges — Europe PMC PMID:42769817},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42769817},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fffbcf91552e; sha256 3031481386e4e3d06ac10871826941449122527dbed967d80998073b3fe487a6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42769817. Agents can read the archived copy with the MCP tool read_document.